Ether

Ether

SCHEMBL158383

CCOCC.COc1ccc(C(=O)C(O)c2ccc(OC)cc2)cc1

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
GABBR2 O75899 1/20 0.45
GABBR1 Q9UBS5 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
GSK3B P49841 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthraquinone SCHEMBL20607636 0.91 MAPT (0.45) HPGDSMN1; SMN2ALDH1A1CES2CES1
SCHEMBL68736 0.90 CES2 (0.55) CA1CA2ALDH1A1CYP1A2CES2
Methoxymethane SCHEMBL36596 0.89 CES2 (0.53) CA1CA2ALDH1A1CYP1A2CES2
SCHEMBL12168990 0.84 NPSR1 (0.56) CA1CA2ALDH1A1CYP1A2CES2
Ether SCHEMBL11870463 0.84 CES2 (0.47) SMN1; SMN2ALDH1A1CES2CES1SLC6A2
SCHEMBL6473480 0.84 MAPT (0.49) CA1CA2SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL12489656 0.83 ALDH1A1 (0.48) CA1CA2SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL4809737 0.83 RAB9A (0.62) CA1CA2ALDH1A1CYP1A2CES2
SCHEMBL1927479 0.83 RAB9A (0.48) CA1CA2SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL5444947 0.83 HPGD (0.62) HPGDSMN1; SMN2ALDH1A1CYP1A2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11203706-B1 Method for making agglomerate particles AMERIPOLISH INC. (US) 2021-12-21 US claimed
US-4167415-A Photocurable composition comprising copolymer of maleic acid monoester and α-olefin compound KANSAI PAINT CO., LTD. (JP) 1979-09-11 US claimed
US-4092172-A Photocurable composition comprising a copolymer of a maleic acid monoester with an α-olefine KANSAI PAINT CO., LTD. (JA) 1978-05-30 US claimed
US-3954584-A Photopolymerizable vinylurethane liquid composition KANSAI PAINT COMPANY (JA) 1976-05-04 US claimed
US-12043754-B2 Two-component type curable resin composition, product, dry film, cured product, and printed wiring board TAIYO HOLDINGS CO., LTD. (JP) 2024-07-23 US disclosed
CN-114258439-B Sheath-core filaments comprising diene-based rubber and method of printing the same 3M创新有限公司 2024-07-12 CN disclosed
US-20240208990-A1 SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2024-06-27 US disclosed
CN-118235089-A Curable resin composition, laminated structure, cured product, and electronic component 太阳控股株式会社 2024-06-21 CN disclosed
US-20240191072-A1 CURABLE RESIN COMPOSITION, DRY FILM, CURED PRODUCT, AND ELECTRONIC COMPONENT TAIYO HOLDING CO., LTD. (JP) 2024-06-13 US disclosed
US-12006464-B2 Shaped siliceous abrasive agglomerate with shaped abrasive particles, abrasive articles, and related methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-06-11 US disclosed
EP-4377367-A1 COMPOSITION INCLUDING MONOMER WITH A CARBOXYLIC ACID GROUP, MONOMER WITH A HYDROXYL GROUP, AN ALKYL MONOMER, AND CROSSLINKER AND RELATED ARTICLE AND METHOD 3M Innovative Properties Company (US) 2024-06-05 EP disclosed
CN-116507680-B Free radically polymerizable crosslinking agent, curable composition, and adhesive therefrom 3M创新有限公司 2024-05-14 CN disclosed
US-4195129-A Method for immobilizing enzymes and microbial cells KANSAI PAINT CO., LTD. (JP) 1980-03-25 US disclosed
US-4181752-A Acrylic-type pressure sensitive adhesives by means of ultraviolet radiation curing MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-01-01 US disclosed
US-4167415-A Photocurable composition comprising copolymer of maleic acid monoester and α-olefin compound KANSAI PAINT CO., LTD. (JP) 1979-09-11 US disclosed
US-4130760-A Reusable radiation monitor MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1978-12-19 US disclosed
US-4092172-A Photocurable composition comprising a copolymer of a maleic acid monoester with an α-olefine KANSAI PAINT CO., LTD. (JA) 1978-05-30 US disclosed
US-4010289-A METHOD OF MANUFACTURING SYNTHETIC RESIN FILM HAVING HIGH WRITABILITY AND PRINTABILITY SHOWA DENKO KABUSHIKI KAISHA (JA) 1977-03-01 US disclosed
US-3954584-A Photopolymerizable vinylurethane liquid composition KANSAI PAINT COMPANY (JA) 1976-05-04 US disclosed
US-3953408-A LITHOGRAPHIC PLATES ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) 1976-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208990-A1 SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME REN, PKD1, SAV1 CA1 429/4885CA2 880/4885HPGD 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.